脓毒症相关急性肾脏疾病的发病率、发展轨迹和结局

IF 3.4 Q1 UROLOGY & NEPHROLOGY Kidney Medicine Pub Date : 2025-03-01 Epub Date: 2024-12-27 DOI:10.1016/j.xkme.2024.100959
Hsiu-Yin Chiang , Chih-Chia Liang , Ya-Luan Hsiao , Uyen-Minh Le , Yi-Ching Chang , Pei-Shan Chen , David Ray Chang , I-Wen Ting , Hung-Chieh Yeh , Chin-Chi Kuo
{"title":"脓毒症相关急性肾脏疾病的发病率、发展轨迹和结局","authors":"Hsiu-Yin Chiang ,&nbsp;Chih-Chia Liang ,&nbsp;Ya-Luan Hsiao ,&nbsp;Uyen-Minh Le ,&nbsp;Yi-Ching Chang ,&nbsp;Pei-Shan Chen ,&nbsp;David Ray Chang ,&nbsp;I-Wen Ting ,&nbsp;Hung-Chieh Yeh ,&nbsp;Chin-Chi Kuo","doi":"10.1016/j.xkme.2024.100959","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><div>Systematic evaluation of the prognosis from sepsis-associated acute kidney disease (SA-AKD) using real-world data is limited. This study aimed to use data algorithms on the electronic health records to trace the SA-AKD trajectory from acute kidney injury (AKI) to chronic kidney disease (CKD).</div></div><div><h3>Study Design</h3><div>A retrospective cohort study.</div></div><div><h3>Setting &amp; Participants</h3><div>Adult inpatients with first sepsis episode surviving 90 days after AKD in a quaternary referral medical center.</div></div><div><h3>Exposure</h3><div>We defined SA-AKD as having sustained ≥1.5-fold increased serum creatinine levels or initiating kidney replacement therapy after the SA-AKI, and we classified SA-AKD into recovery, relapse, and persistent SA-AKD subgroups.</div></div><div><h3>Outcomes</h3><div>All-cause mortality, kidney replacement therapy (KRT), <em>de novo</em> nondialysis dependent CKD (CKD-ND), and late-recovery AKD during 1-year follow-up.</div></div><div><h3>Analytical Approach</h3><div>A multivariable Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Of 24,038 eligible inpatients with sepsis, 42.2% had SA-AKI, and 17.6% progressed to SA-AKD (43.6% recovery, 8.3% relapse, 32.2% persistent, and 15.9% unclassified). Compared with the recovery subgroup, the 1-year mortality risk for the relapse, persistent, and unclassified SA-AKD subgroups were 1.57 (adjusted hazard ratios [aHRs]; 95% CI, 1.22-2.01), 1.36 (1.13-1.63), and 0.65 (0.48-0.89), respectively. Risks of KRT initiation were 3.27 (2.14-4.98), 6.01 (4.41-8.19), and 0.98 (0.55-1.74), respectively, and corresponding aHRs for <em>de novo</em> CKD-ND were 3.84 (2.82-5.22), 3.35 (2.61-4.29), and 0.48 (0.30-0.77), respectively. Patients with relapse SA-AKD had a higher likelihood of late recovery (aHR, 3.62; 95% CI, 2.52-5.21) than the persistent SA-AKD.</div></div><div><h3>Limitations</h3><div>Selection bias and information bias could be present because of limiting population to sepsis survivors and because of no standardized follow-up protocol for kidney function.</div></div><div><h3>Conclusions</h3><div>SA-AKD without recovery is associated with increased and long-term risks of KRT initiation, mortality, and increased risk of <em>de novo</em> CKD-ND for patients initially free of CKD. Further studies are warranted for managing AKI to AKD to CKD in real-world settings.</div></div><div><h3>Plain Language Summary</h3><div>Systematic evaluation of the prognosis for sepsis-associated acute kidney injury (AKI) and sepsis-associated acute kidney disease (AKD) using real-world data remain limited. We applied standard definitions of sepsis and AKI/AKD and comprehensively profiled the AKI-AKD-chronic kidney disease (CKD) trajectory among sepsis survivors in a large, longitudinal hospital-based cohort. Our study showed that sepsis-associated AKD without recovery is associated with elevated and long-term risks of progressing to kidney replacement therapy, mortality, and new onset of CKD. These findings advocate for a paradigm shift toward digital therapies for managing the transition from AKI to AKD to CKD among patients with sepsis.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 3","pages":"Article 100959"},"PeriodicalIF":3.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sepsis-Associated Acute Kidney Disease Incidence, Trajectory, and Outcomes\",\"authors\":\"Hsiu-Yin Chiang ,&nbsp;Chih-Chia Liang ,&nbsp;Ya-Luan Hsiao ,&nbsp;Uyen-Minh Le ,&nbsp;Yi-Ching Chang ,&nbsp;Pei-Shan Chen ,&nbsp;David Ray Chang ,&nbsp;I-Wen Ting ,&nbsp;Hung-Chieh Yeh ,&nbsp;Chin-Chi Kuo\",\"doi\":\"10.1016/j.xkme.2024.100959\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Rationale &amp; Objective</h3><div>Systematic evaluation of the prognosis from sepsis-associated acute kidney disease (SA-AKD) using real-world data is limited. This study aimed to use data algorithms on the electronic health records to trace the SA-AKD trajectory from acute kidney injury (AKI) to chronic kidney disease (CKD).</div></div><div><h3>Study Design</h3><div>A retrospective cohort study.</div></div><div><h3>Setting &amp; Participants</h3><div>Adult inpatients with first sepsis episode surviving 90 days after AKD in a quaternary referral medical center.</div></div><div><h3>Exposure</h3><div>We defined SA-AKD as having sustained ≥1.5-fold increased serum creatinine levels or initiating kidney replacement therapy after the SA-AKI, and we classified SA-AKD into recovery, relapse, and persistent SA-AKD subgroups.</div></div><div><h3>Outcomes</h3><div>All-cause mortality, kidney replacement therapy (KRT), <em>de novo</em> nondialysis dependent CKD (CKD-ND), and late-recovery AKD during 1-year follow-up.</div></div><div><h3>Analytical Approach</h3><div>A multivariable Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Of 24,038 eligible inpatients with sepsis, 42.2% had SA-AKI, and 17.6% progressed to SA-AKD (43.6% recovery, 8.3% relapse, 32.2% persistent, and 15.9% unclassified). Compared with the recovery subgroup, the 1-year mortality risk for the relapse, persistent, and unclassified SA-AKD subgroups were 1.57 (adjusted hazard ratios [aHRs]; 95% CI, 1.22-2.01), 1.36 (1.13-1.63), and 0.65 (0.48-0.89), respectively. Risks of KRT initiation were 3.27 (2.14-4.98), 6.01 (4.41-8.19), and 0.98 (0.55-1.74), respectively, and corresponding aHRs for <em>de novo</em> CKD-ND were 3.84 (2.82-5.22), 3.35 (2.61-4.29), and 0.48 (0.30-0.77), respectively. Patients with relapse SA-AKD had a higher likelihood of late recovery (aHR, 3.62; 95% CI, 2.52-5.21) than the persistent SA-AKD.</div></div><div><h3>Limitations</h3><div>Selection bias and information bias could be present because of limiting population to sepsis survivors and because of no standardized follow-up protocol for kidney function.</div></div><div><h3>Conclusions</h3><div>SA-AKD without recovery is associated with increased and long-term risks of KRT initiation, mortality, and increased risk of <em>de novo</em> CKD-ND for patients initially free of CKD. Further studies are warranted for managing AKI to AKD to CKD in real-world settings.</div></div><div><h3>Plain Language Summary</h3><div>Systematic evaluation of the prognosis for sepsis-associated acute kidney injury (AKI) and sepsis-associated acute kidney disease (AKD) using real-world data remain limited. We applied standard definitions of sepsis and AKI/AKD and comprehensively profiled the AKI-AKD-chronic kidney disease (CKD) trajectory among sepsis survivors in a large, longitudinal hospital-based cohort. Our study showed that sepsis-associated AKD without recovery is associated with elevated and long-term risks of progressing to kidney replacement therapy, mortality, and new onset of CKD. These findings advocate for a paradigm shift toward digital therapies for managing the transition from AKI to AKD to CKD among patients with sepsis.</div></div>\",\"PeriodicalId\":17885,\"journal\":{\"name\":\"Kidney Medicine\",\"volume\":\"7 3\",\"pages\":\"Article 100959\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590059524001705\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524001705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

基本原理及目的利用真实数据系统评价脓毒症相关急性肾病(SA-AKD)的预后是有限的。本研究旨在利用电子健康记录上的数据算法来追踪从急性肾损伤(AKI)到慢性肾脏疾病(CKD)的SA-AKD轨迹。研究设计:回顾性队列研究。设置,参与者:在一家四级转诊医疗中心,首次脓毒症发作的成年住院患者在AKD后存活90天。我们将SA-AKD定义为在SA-AKI后血清肌酐水平持续升高≥1.5倍或开始肾脏替代治疗,并将SA-AKD分为恢复期、复发期和持续性SA-AKD亚组。结果:1年随访期间,全因死亡率、肾脏替代治疗(KRT)、新发非透析依赖性CKD (CKD- nd)和晚期恢复性AKD。分析方法:多变量Cox比例风险模型。结果24,038例符合条件的脓毒症住院患者中,42.2%患有SA-AKI, 17.6%进展为SA-AKD(43.6%恢复,8.3%复发,32.2%持续,15.9%未分类)。与恢复亚组相比,复发、持续性和未分类SA-AKD亚组的1年死亡风险为1.57(校正风险比[aHRs];95% CI分别为1.22-2.01)、1.36(1.13-1.63)和0.65(0.48-0.89)。KRT启动的风险分别为3.27(2.14-4.98)、6.01(4.41-8.19)和0.98 (0.55-1.74),CKD-ND的相应ahr分别为3.84(2.82-5.22)、3.35(2.61-4.29)和0.48(0.30-0.77)。复发的SA-AKD患者晚期恢复的可能性更高(aHR, 3.62;95% CI, 2.52-5.21)优于持续性SA-AKD。局限性:选择偏倚和信息偏倚可能存在,因为脓毒症幸存者的人群有限,也因为肾功能没有标准化的随访方案。结论:未恢复的sa - akd与KRT启动、死亡率和最初无CKD的患者新发CKD- nd的风险增加和长期风险相关。在现实环境中,AKI到AKD再到CKD的管理需要进一步的研究。使用真实世界数据对败血症相关急性肾损伤(AKI)和败血症相关急性肾脏疾病(AKD)的预后进行系统评估仍然有限。我们应用了脓毒症和AKI/AKD的标准定义,并在一个大型的纵向医院队列中全面描述了脓毒症幸存者的AKI-AKD-慢性肾脏疾病(CKD)轨迹。我们的研究表明,脓毒症相关的AKD未恢复与进展为肾脏替代治疗、死亡率和新发CKD的风险升高和长期风险相关。这些发现提倡在脓毒症患者中进行从AKI到AKD再到CKD的数字化治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sepsis-Associated Acute Kidney Disease Incidence, Trajectory, and Outcomes

Rationale & Objective

Systematic evaluation of the prognosis from sepsis-associated acute kidney disease (SA-AKD) using real-world data is limited. This study aimed to use data algorithms on the electronic health records to trace the SA-AKD trajectory from acute kidney injury (AKI) to chronic kidney disease (CKD).

Study Design

A retrospective cohort study.

Setting & Participants

Adult inpatients with first sepsis episode surviving 90 days after AKD in a quaternary referral medical center.

Exposure

We defined SA-AKD as having sustained ≥1.5-fold increased serum creatinine levels or initiating kidney replacement therapy after the SA-AKI, and we classified SA-AKD into recovery, relapse, and persistent SA-AKD subgroups.

Outcomes

All-cause mortality, kidney replacement therapy (KRT), de novo nondialysis dependent CKD (CKD-ND), and late-recovery AKD during 1-year follow-up.

Analytical Approach

A multivariable Cox proportional hazards models.

Results

Of 24,038 eligible inpatients with sepsis, 42.2% had SA-AKI, and 17.6% progressed to SA-AKD (43.6% recovery, 8.3% relapse, 32.2% persistent, and 15.9% unclassified). Compared with the recovery subgroup, the 1-year mortality risk for the relapse, persistent, and unclassified SA-AKD subgroups were 1.57 (adjusted hazard ratios [aHRs]; 95% CI, 1.22-2.01), 1.36 (1.13-1.63), and 0.65 (0.48-0.89), respectively. Risks of KRT initiation were 3.27 (2.14-4.98), 6.01 (4.41-8.19), and 0.98 (0.55-1.74), respectively, and corresponding aHRs for de novo CKD-ND were 3.84 (2.82-5.22), 3.35 (2.61-4.29), and 0.48 (0.30-0.77), respectively. Patients with relapse SA-AKD had a higher likelihood of late recovery (aHR, 3.62; 95% CI, 2.52-5.21) than the persistent SA-AKD.

Limitations

Selection bias and information bias could be present because of limiting population to sepsis survivors and because of no standardized follow-up protocol for kidney function.

Conclusions

SA-AKD without recovery is associated with increased and long-term risks of KRT initiation, mortality, and increased risk of de novo CKD-ND for patients initially free of CKD. Further studies are warranted for managing AKI to AKD to CKD in real-world settings.

Plain Language Summary

Systematic evaluation of the prognosis for sepsis-associated acute kidney injury (AKI) and sepsis-associated acute kidney disease (AKD) using real-world data remain limited. We applied standard definitions of sepsis and AKI/AKD and comprehensively profiled the AKI-AKD-chronic kidney disease (CKD) trajectory among sepsis survivors in a large, longitudinal hospital-based cohort. Our study showed that sepsis-associated AKD without recovery is associated with elevated and long-term risks of progressing to kidney replacement therapy, mortality, and new onset of CKD. These findings advocate for a paradigm shift toward digital therapies for managing the transition from AKI to AKD to CKD among patients with sepsis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
期刊最新文献
Concordance Analysis Between KDIGO Definition of Acute Kidney Injury and Its Coding in Clinical Practice Patients’ Perceptions of Kidney Transplant Failure and Return to Dialysis IgA-Dominant Infection-Related Glomerulonephritis Due to Mycobacterium avium: A Case Report Clinical Features and Outcomes of Recurrent IgA Nephropathy After Transplantation: A Case Series and Comparison to Native Disease First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1